Originally published In Press as doi:10.1074/jbc.M000438200 on April 6, 2000
J. Biol. Chem., Vol. 275, Issue 25, 19241-19249, June 23, 2000
Overexpression of Catalase in the Mitochondrial or Cytosolic
Compartment Increases Sensitivity of HepG2 Cells to Tumor Necrosis
Factor-
-induced Apoptosis*
Jingxiang
Bai and
Arthur I.
Cederbaum
From the Department of Biochemistry and Molecular Biology, Mount
Sinai School of Medicine, New York, New York 10029
Received for publication, January 20, 2000, and in revised form, March 16, 2000
 |
ABSTRACT |
The sensitivity of HepG2 cells overexpressing
catalase in either the cytosolic or mitochondrial compartment to tumor
necrosis factor-
(TNF-
) and cycloheximide was studied. Cells
overexpressing catalase in the cytosol (C33 cells) and especially in
mitochondria (mC5 cells) were more sensitive to TNF-
-induced
apoptosis than were control cells (Hp cells). The activities of
caspase-3 and -8 were increased by TNF-
, with the highest activities
found in mC5 cells. Sodium azide, an inhibitor of catalase, reduced the
increased sensitivity of mC5 and C33 cells to TNF-
to the level of
toxicity found with control Hp cells. Azide also decreased the elevated
caspase-3 activity of mC5 cells. A pan-caspase inhibitor prevented the
TNF-
-induced apoptosis and toxicity produced by catalase
overexpression. Addition of H2O2
prevented TNF-
-induced apoptosis and caspase activation, an effect
prevented by simultaneous addition of catalase. TNF-
plus
cycloheximide increased ATP levels, with higher levels in C33 and mC5
cells compared with Hp cells. TNF-
did not produce apoptosis in mC5
cells maintained in a low energy state. TNF-
signaling was not
altered by the overexpression of catalase, as activation of nuclear
factor
B and AP-1 by TNF-
was similar in the three cell lines.
These results suggest that catalase, overexpressed in the cytosolic or
especially the mitochondrial compartment, potentiates TNF-
-induced
apoptosis and activation of caspases by removal of
H2O2.
 |
INTRODUCTION |
Apoptosis, a major form of cell death, is characterized by early
and prominent condensation of nuclear chromatin, cell shrinkage, activation of proteases and endonucleases, enzymatic cleavage of the
DNA into 180-base pair oligonucleosomal fragments, and segmentation of
the cells into membrane-bound apoptotic bodies (1, 2). The most
critical protease families implicated in apoptosis are cysteine
proteases known as caspases (3, 4). Caspases are constitutively present
in cells as zymogens and require proteolytic cleavage into the
catalytic active heterodimer. Inhibiting the activation of caspases
suppresses the ability of cells to undergo apoptosis or causes a switch
from apoptosis to necrosis (4, 5).
Reactive oxygen species
(ROS)1 are thought to be
involved in many forms of apoptosis. Increased levels of ROS have been
detected in cells undergoing apoptosis (5, 6). Oxidative stress also affects the process of apoptosis. For example, treatment of cells in vitro with H2O2 causes either
apoptosis or necrosis depending on the concentration of
H2O2 employed and the type of cells being studied (7, 8). Recent reports indicated that oxidative stress inhibits
apoptosis induced by the chemotherapeutic drug VP-16 (9) or by
CD95
(5).
TNF-
is a cytokine produced by a wide variety of cell types whose
production is up-regulated in a number of stressful and pathological
conditions (10, 11). TNF-
expression is increased in animal models
of toxic liver injury (12, 13) and in humans during alcohol-induced
liver disease (14, 15). TNF-
kills cancer cells in intact animals
and a variety of cell lines in vitro by inducing these cells
to undergo either apoptosis or necrosis. However, the biochemical basis
for the cytotoxic action of TNF-
is still largely unknown. TNF-
has to been shown to increase production of ROS, and this appears to be
an important step in its cytotoxic mechanism (16, 17). Although some
studies reported that antioxidants could protect against TNF-
toxicity (18, 19), there are other reports that antioxidants including
catalase did not prevent TNF-
-mediated cell death (20).
In a previous study (21), stable HepG2 cell lines overexpressing
catalase in the cytosol or mitochondria were established by
transfection with catalase cDNA or with a catalase cDNA with a
manganese-superoxide dismutase mitochondrial leader sequence that could
conduct catalase into mitochondria. We found that the cells
overexpressing catalase in either cellular compartment were more
resistant to H2O2-, menadione-, or antimycin
A-induced toxicity and apoptosis compared with cells transfected with
the empty plasmid vector. In view of the conflicting reports concerning
the ability of antioxidants to prevent TNF-
toxicity, and since one
major locus of TNF-
-induced oxidative stress appears to be the
mitochondrial compartment, studies were carried out to investigate the
sensitivity of HepG2 cells that overexpress catalase in the cytosol or
mitochondria to apoptosis induced by TNF-
. To our surprise and in
contrast to the decreased sensitivity to H2O2,
menadione, or antimycin A, cells overexpressing catalase, especially in
the mitochondrial compartment, displayed an increased sensitivity to
TNF-
-induced apoptosis.
 |
MATERIALS AND METHODS |
Reagents--
Recombinant human TNF-
, cycloheximide (CHX),
sodium azide, hydrogen peroxide (H2O2),
horseradish peroxidase-conjugated goat anti-rabbit IgG, MEM, and fetal
bovine serum were purchased from Sigma. Propidium iodide was purchased
from Molecular Probes, Inc. (Eugene, OR). Bovine catalase, caspase
inhibitor I, substrates of caspase-3 and -8, and polyclonal antibodies
raised in rabbit against human caspase-3 or cytochrome c
were obtained from Calbiochem. Zeocin for selection was from Invitrogen
(Carlsbad, CA).
Cell Lines and Cell Culture--
HepG2 cells overexpressing
cytosolic catalase (C33 cells) and mitochondrial catalase (mC5 cells)
as well as control cells (Hp cells) were established in our laboratory
previously (21) by transfection with plasmid vector pZeoSV2(+)
containing human catalase cDNA (pZeoSV-CAT), plasmid vector
pZeoSV2(+) containing human catalase cDNA with a
manganese-superoxide dismutase mitochondrial leader sequence
(pZeoSV/MSP-CAT), and empty vector pZeoSV2(+) into HepG2 cells. Cells
were cultured in MEM containing 10% fetal calf serum, 100 units/ml
penicillin, 100 µg/ml streptomycin, 300 µg/ml Zeocin, and 2 mM glutamine in a humidified atmosphere in 5%
CO2 at 37 °C.
DNA Fragmentation Assay--
The DNA fragmentation pattern (DNA
ladder) was carried out by agarose gel electrophoresis. Cells (1×
106) treated with various reagents were scraped and
centrifuged at 1200 rpm for 10 min. The cell pellet was resuspended in
1 ml of lysis buffer consisting of 10 mM Tris-HCl, pH 7.4, 10 mM NaCl, 10 mM EDTA, 100 µg/ml proteinase
K, and 0.5% SDS and incubated for 2 h at 50 °C. DNA was
extracted with 1 ml of phenol, pH 8.0, followed by extraction with 1 ml
of phenol/chloroform (1:1) and chloroform. The aqueous phase was
precipitated with 2.5 volumes of ice-cold ethanol and 0.1 volume of 3 M sodium acetate, pH 5.2, at
20 °C overnight. The
precipitates were collected by centrifugation at 13,000 × g for 10 min. The pellets were air-dried and resuspended in
50 µl of Tris/EDTA buffer supplemented with 100 µg/ml RNase A. DNA
was loaded onto a 1.5% agarose gel containing ethidium bromide,
electrophoresed in Tris acetate/EDTA buffer for 2 h at 50 V, and
photographed under UV illumination.
DNA Analysis by Flow Cytometry--
Flow cytometry DNA analysis
was used to quantify the percentage of apoptotic cells. Cells (5 × 105) were seeded onto six-well plates and incubated with
various reagents. At different time points, cells were harvested by
trypsinization and washed with PBS, followed by centrifugation at 2000 rpm for 10 min. The cell pellet was resuspended in 80% ethanol and
stored at 4 °C for 24 h. Cells were washed twice with PBS. The
pellet was resuspended in PBS containing 100 µg/ml RNase A, incubated at 37 °C for 30 min, stained with propidium iodide (50 µg/ml), and
analyzed by flow cytometry DNA analysis as described previously (21).
Caspase Activity Assay--
Hp, C33, and mC5 cells treated as
described in the figure legends were harvested by scraping from the
dishes, washed with ice-cold PBS, and resuspended in lysis buffer
containing 50 mM Hepes, pH 7.5, 10% sucrose, and 0.1%
Triton X-100 on ice for 30 min. After centrifugation at 16,000 × g for 20 min at 4 °C, supernatants were transferred to
new tubes. Protein concentration was measured with the DC protein assay
reagent (Bio-Rad). Caspase-3 activity was measured in the supernatant
using the CaspACETM assay system kit (Promega) by following
the cleavage of 50 µM acetyl-Asp-Glu-Val-Asp
7-amino-4-methylcoumarin. The fluorescence of the cleaved
7-amino-4-methylcoumarin substrate was determined using a fluorescence
spectrophotometer (Perkin-Elmer 650-10S, Hitachi, Ltd.) set at an
excitation wavelength of 360 nm and an emission wavelength of 460 nm.
The same method was used to measure the activity of caspase-8 using 50 µM benzyloxycarbonyl-Ile-Glu-Thr-Asp 7-amino-4-trifluoromethylcoumarin as a substrate and 400 nm as the
excitation wavelength and 505 nm as the emission wavelength. Activities
are expressed as arbitrary units of fluorescence.
Western Blotting--
To detect procaspase-3, cells treated with
or without TNF-
plus CHX were washed twice with PBS, harvested by
scraping, and subsequently sonicated at duty cycle 50% and output
control 4 for 10 s (Heat Systems-Ultrasonics, Inc.). The sonicated
suspensions were centrifuged at 10,000 × g for 10 min
at 4 °C. The supernatant was transferred to a new tube, and the
protein concentration was measured. To detect cytochrome c,
a post-mitochondrial supernatant fraction was prepared by
homogenization and differential centrifugation as described previously
(21). 50 µg (for procaspase-3) or 20 µg (for cytochrome
c) of denatured protein was resolved on 15% SDS-polyacrylamide gel and electroblotted onto nitrocellulose membranes
(Bio-Rad). The membrane was incubated with rabbit anti-human caspase-3
(1:300) or rabbit anti-human cytochrome c (1:1000)
polyclonal antibody as the primary antibody, followed by incubation
with horseradish peroxidase-conjugated goat anti-rabbit IgG as the secondary antibody (1:5000). Detection by the chemiluminescence reaction was carried out for 1 min using the ECL kit (Amersham Pharmacia Biotech, Buckinghamshire, United Kingdom).
Gel Shift Assay--
Cells treated with medium or with medium
containing 15 ng/ml TNF-
for 15 or 30 min were harvested by scraping
and centrifugation. The cell pellets were resuspended in 800 µl of
buffer containing 10 mM Hepes, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM
dithiothreitol, and 0.5 mM phenylmethylsulfonyl fluoride.
After incubation on ice for 15 min, 50 µl of 10% Nonidet P-40 was
added; the lysed cells were mixed in a Vortex mixer for 10 s and
then spun down (13,000 × g, 1 min, 4 °C); and the
supernatant was removed. The nuclear pellet was quickly resuspended in
400 µl of buffer containing 20 mM Hepes, 400 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM dithiothreitol, and 1 mM
phenylmethylsulfonyl fluoride. The nuclei were extracted on ice for 15 min with Vortex mixing every minute. The nuclei were then pelleted by
centrifugation (13,000 × g, 5 min, 4 °C); the
supernatant, considered as the nuclear extract, was removed; and the
protein concentration was measured.
The DNA binding reaction was performed using the gel shift assay system
from Promega according to the instructions of the manufacturer. 2-5
µg of nuclear extract was incubated in gel shift binding buffer for
10 min at room temperature. NF-
B and AP-1 DNA probes (5'-AGT TGA GGG
GAC TTT CCC AGG C-3' and 5'-CGC TTG ATG AGT CAG CCG GAA-3',
respectively) were labeled with [
-32P]ATP by T4
polynucleotide kinase. Approximately 10,000 cpm of 32P-labeled DNA probe was then added to the nuclear extract
in binding buffer and allowed to bind for 30 min. The reaction was then
loaded onto a 4% nondenaturing acrylamide gel. After gel
electrophoresis, the gels were dried and exposed to Kodak XAR5 film.
ATP Assay--
Intracellular ATP levels were determined using
the ENLITENTM ATP assay kit (Promega). Hp, C33, and mC5
cells (~5 × 105 cells) were treated with or without
TNF-
/CHX for 3 h. Cells were washed twice with ice-cold PBS,
and 250 µl of ice-cold 2.5% (w/v) trichloroacetic acid was added to
the six-well dishes. After scrapping from the dish, the cell extract
was immediately centrifuged at 10,000 × g for 5 min at
4 °C. The supernatant was diluted 10 times and neutralized with Tris
acetate buffer, pH 7.75. 10-µl samples and 100 µl of
luciferin-luciferase reagent were used for ATP measurements according
to the instructions of the manufacturer (Promega). Luminescence units
were measured using a Model 1251 luminometer (LKB Wallac). The relative
luminescence units were used as an index of the intracellular ATP levels.
Statistics--
Results are expressed as means ± S.E. The
numbers of experiments are indicated in the figure legends. Statistical
evaluation was carried out using Student's t test.
 |
RESULTS |
HepG2 cells were transfected with empty plasmid or plasmid
containing human catalase cDNA or human catalase cDNA with a
80-base pair manganese-superoxide dismutase mitochondrial leader
sequence, and stable cells were generated (21). Catalase activity was increased from values of ~40 units/mg of total cell protein in the
cells transfected with empty vector (Hp cells) to values of 100-120
units/mg of cell protein in the cells transfected with catalase
cDNA (C33 cells) or catalase cDNA with the mitochondrial leader
sequence (mC5 cells). Isolated mitochondria from Hp or C33 cells
displayed low catalase activity (<10 units/mg of mitochondrial protein) compared with mitochondria from mC5 cells (~140 units/mg of
mitochondrial protein). Western blot analyses showed similar results as
the catalase activity assays, with levels of catalase protein
increasing at least 2-fold in the cell extract from C33 or mC5 cells
compared with Hp cells. Catalase was barely detectable in mitochondria
isolated from Hp or C33 cells, whereas a prominent band with at least
10-fold increased staining intensity was found in mitochondria isolated
from mC5 cells. The activity of the other major enzyme system for
removal of H2O2, the glutathione peroxidase system, was found to be similar for all three cell lines; total cellular glutathione peroxidase activity was between 17.1 and 19.6 milliunits/mg of cell protein for the three cell lines, whereas mitochondrial glutathione peroxidase activity ranged between 6.1 and
6.7 milliunits/mg of mitochondrial protein for the three cell lines.
Overexpression of Catalase in the Cytosol or Mitochondria Increases
Sensitivity to TNF-
-induced Apoptosis--
HepG2 cells are known to
be resistant to TNF-
-induced apoptosis; however, by combining with
CHX or actinomycin D, TNF-
induces typical apoptosis at low
concentrations and at short times (22). The appearance of apoptosis
morphology, including cell shrinkage, membrane blebbing, and formation
of apoptotic bodies, and biochemical changes such as DNA fragmentation
and the activation of caspases occurs in the presence of TNF-
plus
CHX. Hp, C33, and mC5 cells were treated with medium or with medium
containing 15 ng/ml TNF-
and 40 µM CHX for 4, 8, and
12 h, and apoptosis was evaluated by a DNA fragmentation assay and
by flow cytometry DNA analysis. Both assays showed that C33 cells and
especially mC5 cells were more sensitive to TNF-
/CHX-induced
apoptosis than were Hp cells (Fig. 1).
DNA fragmentation assays showed clear DNA ladders in C33 cells (Fig.
1A, lane 7) and mC5 cells (lane 11) as
early as 4 h in response to the TNF-
/CHX treatment, whereas no
DNA ladder or a weak DNA ladder was seen in Hp cells at 4 h and
even 8 h (lanes 3 and 4), respectively. A
clear DNA ladder was observed in Hp cells 12 h after the
TNF-
/CHX treatment (lane 5), and this was intensified in
C33 cells (lane 9) and especially in mC5 cells (lane
13). The hypodiploidy of cellular DNA measured by flow cytometry after propidium iodide staining was used to indicate the percentage of
apoptotic cells. These percentages were 9, 17, and 18% at 4, 8, and
12 h in Hp cells, respectively (Fig. 1B, white
bars), and increased to 13, 33, and 35% in C33 cells
(light-gray bars) and dramatically increased to 48, 57, and
73% in mC5 cells (dark-gray bars) at 4, 8, and 12 h,
respectively. The histograms of Hp, C33, and mC5 cells treated with
medium (control) or with TNF-
/CHX for 8 h are shown in Fig.
1C.

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 1.
Overexpression of catalase increases
sensitivity to TNF- -induced apoptosis.
Hp, C33, and mC5 cells were treated with medium or with medium
containing 15 ng/ml TNF- and 40 µM CHX for 4, 8, and
12 h. A, DNA fragmentation. DNA was extracted and
electrophoresed on a 1.5% agarose gel. Lane 1, 100-base
pair standard ladder; lanes 2-5, 6-9, and
10-13, Hp, C33, and mC5 cells, respectively, treated with
medium (lanes 2, 6, and 10) or with
TNF- /CHX for 4 h (lanes 3, 7, and
11), 8 h (lanes 4, 8, and
12), and 12 h (lanes 5, 9, and
13). B, bar graph showing the percent
of apoptotic cells as measured by flow cytometry. The first group of
bars is cells incubated with control medium; the second, third, and
fourth groups of bars are cells treated with TNF- and CHX for 4, 8, and 12 h, respectively. C, histograms of DNA
analysis by flow cytometry. Hp, C33, or mC5 cells were incubated with
medium (left panels) or with medium containing 15 ng/ml
TNF- and 40 µM CHX (right panels) for
8 h. The percentages of cells in the zone 1 hypodiploid area are
depicted on the graphs.
|
|
Overexpression of Catalase Increases TNF-
Activation of Caspase
Activity--
Activation of caspases, especially caspase-3, occurs in
many models of apoptosis. In the absence of TNF-
/CHX, the activity of caspase-3 was very low and similar in the three cell lines (Fig.
2). Caspase-8 activity was higher, but
also similar in the three cell lines. Addition of TNF-
/CHX increased
caspase-3 activity in Hp cells, whereas only a small increase in
caspase-8 activity was observed. The TNF-
/CHX activation of caspase
activity was greater in C33 cells than in Hp cells and was highest in
mC5 cells (Fig. 2). The increase in caspase-3 activity produced by
TNF-
/CHX was >2-fold higher in mC5 cells than in Hp cells.

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 2.
Caspase activity. Hp, C33, or mC5 cells
were incubated with medium (control bars) or with medium
containing 15 ng/ml TNF- and 40 µM CHX (TNF+CHX
bars) for 6 h. The activities of caspase-3 (upper
panel) and caspase-8 (lower panel) were measured as
described under "Materials and Methods." Results are representative
of at least three independent experiments.
|
|
Inhibiting Catalase with Sodium Azide Decreases Apoptosis and
Caspase Activation Produced by TNF-
--
The only apparent
difference between Hp cells and C33 or mC5 cells is the increased
activity and content of catalase in the cytosol or mitochondria of the
latter compared with the former. To validate that the increased
sensitivity of C33 and mC5 cells to TNF-
is indeed due to
overexpression of catalase, the effect of sodium azide on
TNF-
/CHX-induced apoptosis and caspase activation was determined.
Addition of sodium azide to a final concentration of 1 mM
resulted in a 70% decrease in catalase activity in C33 and mC5 cells.
As shown in Fig. 3A,
pretreating the cells with 1 mM sodium azide for 6 h,
followed by incubation with 15 ng/ml TNF-
and 40 µM
CHX for 6 h, resulted in an inhibition of the TNF-
-induced DNA
ladder formation in all three cell lines (compare lanes 4,
7, and 10 with lanes 3, 6,
and 9). Similarly, sodium azide lowered the percentage of
cells undergoing apoptosis in the presence of TNF-
/CHX (Fig.
3B). This prevention of apoptosis by sodium azide was
observed in all three cell lines, and much of the increase in apoptosis
found in C33 and mC5 cells was prevented by sodium azide (percent
apoptosis induced by TNF-
/CHX was 16, 33, and 41% in Hp, C33, and
mC5 cells in the absence of sodium azide and 8, 12, and 15% in its
presence). The striking increase in caspase-3 activity induced by
TNF-
/CHX in mC5 cells was also reduced by sodium azide (Fig.
3C).

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 3.
Effect of sodium azide, an inhibitor
of catalase, on apoptosis and caspase activation induced by
TNF- /CHX. Hp, C33, and mC5 cells were
pretreated with or without 1 mM sodium azide for 6 h,
followed by incubation with 15 ng/ml TNF- and 40 µM
CHX for 6 h. A, DNA fragmentation. Lane 1,
100-base pair standard ladder; lanes 2-4, 5-7,
and 8-10, Hp, C33, and mC5 cells, respectively, treated
with medium (lanes 2, 5, and 8),
TNF- /CHX (lanes 3, 6, and 9), and
sodium azide + TNF- /CHX (lanes 4, 7, and
10). B, bar graph showing
the percent of apoptotic cells as measured by flow cytometry.
White bars, cells treated with medium (control);
light-gray bars, cells incubated with TNF- /CHX;
dark-gray bars, cells incubated with sodium azide
(NaAz) + TNF- /CHX. Concentrations and incubation times
are the same as described for A. C, caspase-3
activity in mC5 cells pretreated with or without sodium azide for
6 h, followed by incubation with 15 ng/ml TNF- and 40 µM CHX for an additional 6 h. First bar,
cells treated with medium as a control; second bar, cells
treated with TNF- /CHX; third and fourth bars,
cells pretreated with 1 and 3 mM sodium azide followed by
TNF- /CHX (T/C), respectively.
|
|
H2O2 Inhibits Apoptosis Induced by
TNF-
/CHX--
The increased sensitivity of C33 and mC5 cells to
TNF-
/CHX and the prevention of TNF-
toxicity by sodium azide
suggest that H2O2 may be a key modulator of
sensitivity to TNF-
. To evaluate this, Hp, C33, and mC5 cells were
incubated with 15 ng/ml TNF-
and 40 µM CHX in the
absence or presence of 200 µM
H2O2; and after 6 h, apoptosis was
determined by the DNA fragmentation assay. H2O2
completely inhibited apoptosis in Hp cells (Fig.
4A, lanes 3 and
4) and partially inhibited apoptosis in C33 and mC5 cells (lanes 8 and 9 and lanes 13 and
14, respectively). Adding catalase to the medium abolished
this inhibitory effect of H2O2 and
reestablished TNF-
-induced apoptosis (lanes 5,
10, and 15). At this dosage and time, cells did
not show significant necrosis caused by H2O2. The increase in caspase-3 activity produced by TNF-
/CHX in all three
cell lines was largely prevented by 200 µM
H2O2 (Fig. 4B). H2O2 also produced inhibition of caspase-8
activity, which was slightly increased by addition of TNF-
/CHX; the
inhibition of caspase-8 activity by H2O2 was
less than the inhibition of caspase-3 activity (Fig. 4B).
The inhibition of TNF-
-induced caspase activation by
H2O2 was confirmed by Western blot analysis of
the levels of procaspase-3. Addition of TNF-
/CHX to Hp cells and
especially to mC5 cells decreased the levels of procaspase-3 (Fig.
4C, compare lanes 2 and 6 with
lanes 1 and 5), consistent with the cleavage of
the procaspase form to the active caspase-3 fragments.
H2O2 prevented the TNF-
-induced cleavage of
procaspase-3 especially in Hp cells, which show the least sensitivity
to TNF-
-induced apoptosis (lane 3).

View larger version (35K):
[in this window]
[in a new window]
|
Fig. 4.
H2O2 and
a pan-caspase inhibitor prevent apoptosis and caspase
activation induced by TNF- /CHX. Hp, C33,
and mC5 cells were treated with medium alone or with 200 µM H2O2 or 50 µM
Z-VAD-fmk together with 15 ng/ml TNF- and 40 µM CHX
for 6 h. A, DNA fragmentation. Lane 1,
100-base pair standard ladder; lanes 2-6, 7-11,
and 12-16, Hp, C33, and mC5 cells, respectively, treated
with medium only (lanes 2, 7, and 12),
TNF- /CHX (lanes 3, 8, and 13),
H2O2 + TNF- /CHX (lanes 4,
9, and 14), 500 units/ml catalase + H2O2 + TNF- /CHX (lanes 5,
10, and 15), and Z-VAD-fmk + TNF- /CHX
(lanes 6, 11, and 16). B,
bar graphs showing caspase-3 (upper panel) and
caspase-8 (lower panel) activities in Hp (white
bars), C33 (light-gray bars), and mC5 (dark-gray
bar) cells treated with medium alone (control bars) or
with 15 ng/ml TNF- and 40 µM CHX in the absence or
presence of either 200 µM H2O2 or
50 µM Z-VAD-fmk. C, Western blot analysis of
the level of procaspase-3 (32 kDa) in Hp (lanes 1-4) and
mC5 (lanes 5-8) cells. Lanes 1 and 5,
cells treated with medium as control; lanes 2 and
6, cells treated with TNF- /CHX; lanes
3 and 7, cells treated with TNF- /CHX + 200 µM H2O2; lanes
4 and 8, cells treated with TNF- /CHX + 50 µM Z-VAD-fmk.
|
|
Effect of Z-VAD-fmk, a Pan-Caspase Inhibitor, on TNF-
/CHX
Toxicity--
The activation of caspases such as caspase-3 in all
three cell lines upon addition of TNF-
/CHX, the increased activation of caspase-3 in mC5 cells, and the inhibition by
H2O2 of TNF-
-induced apoptosis and caspase-3
activation suggest that caspases play an important role in the
developing apoptosis and in the different sensitivity of Hp, C33, and
mC5 cells to TNF-
. This was validated by studying the effect of
Z-VAD-fmk, an inhibitor of caspase-3 as well as several other caspases,
on the TNF-
toxicity. At a final concentration of 50 µM, Z-VAD-fmk prevented the induction of apoptosis by
TNF-
/CHX in all three cell lines (Fig. 4A, compare lanes 6, 11, and 16 with lanes
3, 8, and 13), prevented the activation of
caspase-3 by TNF-
/CHX in all three cell lines (Fig. 4B),
and prevented the TNF-
/CHX-induced cleavage of procaspase-3 (Fig. 4C, compare lane 4 with lane 2 and
lane 8 with lane 6). Caspase-8 activity was not
inhibited by Z-VAD-fmk at a concentration that strongly inhibited
caspase-3 activity (Fig. 4B). In summary, the results of
Fig. 4 show that the TNF-
/CHX-induced apoptosis and activation of
caspase-3 and the increased sensitivity of C33 cells and especially mC5
cells to TNF-
/CHX can be prevented by H2O2 and by the caspase inhibitor Z-VAD-fmk.
Release of Cytochrome c--
Release of cytochrome c
from the mitochondria to the cytosol occurs in certain systems
undergoing apoptosis (23, 24). Cytochrome c in conjunction
with caspase-9 can activate caspase-3 (25). The possible presence of
cytochrome c in the post-mitochondrial supernatant fraction
of Hp, C33, or mC5 cells was evaluated by Western blot analysis 4 and
6 h after addition of TNF-
plus CHX to the incubation system, a
time frame when apoptosis is occurring. Very low levels of cytochrome
c were detected in all three cell lines under these
conditions (Fig. 5). Increased release of
cytochrome c from the mitochondria does not appear to be
responsible for the increased caspase-3 activity and sensitivity to
apoptosis of mC5 cells treated with TNF-
/CHX.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 5.
Release of cytochrome c from
mitochondria to the cytosol. Hp, C33, and mC5 cells were treated
with 15 ng of TNF- and 40 µM CHX for 0 h
(lanes 3, 6, and 9), 4 h
(lanes 4, 7, and 10), and 6 h
(lanes 5, 8, and 11). The cytosolic
fraction was then isolated by homogenization followed by differential
centrifugation, and Western blot analysis for cytochrome c
was carried out using anti-cytochrome c polyclonal antibody
(1:1000). Pure cytochrome c (lane 1) and 10 µg
of mitochondrial protein (lane 2) were used as positive
controls.
|
|
Activation of NF-
B and AP-1 by TNF-
--
Activation of
oxidant-sensitive transcription factors such as NF-
B by TNF-
has
been observed in many experimental models (26-28). It is generally
believed that activation of NF-
B and the subsequent activation of
NF-
B-responsive genes are a cellular response to minimize the
toxicity of TNF-
(29-31). Could the increased sensitivity of C33
and mC5 cells to TNF-
reflect a failure to activate NF-
B in these
cells (i.e. overexpression of catalase in C33 or mC5 cells
minimizes TNF-
production of ROS and ROS activation of NF-
B
(32))? We initially discounted differences in protective responses by
NF-
B activation in the three cell lines because the presence of CHX,
which was required for the TNF-
toxicity, would prevent synthesis of
short-lived death antagonists; indeed, the requirement for CHX to
observe TNF-
toxicity is likely due to the failure to synthesize
protective factors. To study this further, the ability of TNF-
to
activate NF-
B and AP-1 was evaluated by electrophoretic mobility gel
shift assays. As shown in Fig.
6A, all three cell lines
showed a very early response to TNF-
addition with respect to
activation of NF-
B; increased binding to a NF-
B consensus
sequence could be observed 15 min after addition of TNF-
. Similarly,
all three cell lines showed a low activation of AP-1 binding, which
increased 15 and 30 min after addition of TNF-
(Fig. 6B).
In general, activation of NF-
B and AP-1 by TNF-
appeared to be
similar in the three cell lines. Importantly, this suggests that
TNF-
binding and signal transduction are not significantly altered
by the overexpression of catalase.

View larger version (61K):
[in this window]
[in a new window]
|
Fig. 6.
Analysis of NF- B
(A) and AP-1 (B) binding activities
in Hp, C33, and mC5 cells. Nuclear extracts from Hp (lanes
1-3), C33 (lanes 4-6), and mC5 (lanes
7-9) cells treated with medium (lanes 1, 4,
and 7) or with 15 ng/ml TNF- for 15 min (lanes
2, 5, and 8) or 30 min (lanes 3,
6, and 9) were incubated with
32P-labeled NF- B (A) or AP-1 (B)
oligonucleotide probe. Unlabeled excess oligonucleotide (1.75 pmol) was
used as a specific competitor (lane 10). Results were
examined by electrophoretic mobility shift assays and visualized by
exposure to Kodak XAR5 film. NS, not specific.
|
|
Effect of TNF-
/CHX on Intracellular ATP Levels--
ATP is
necessary for cells to undergo apoptosis (33, 34), and ATP levels are
changed during the process of apoptosis (35). Experiments were carried
out to evaluate the ATP levels in the cells after incubation in the
absence or presence of TNF-
/CHX. Under basal conditions, the
intracellular ATP level in C33 cells was two times higher than in Hp or
mC5 cells (Fig. 7); the ATP level in mC5
cells was the same as that in Hp cells. After 3 h of treatment
with TNF-
/CHX, intracellular ATP levels in all cells increased,
consistent with the need for ATP for apoptosis (Fig. 7). ATP levels in
C33 and mC5 cells were 50% higher than in Hp cells, which may reflect
the increase in apoptosis in these cells.

View larger version (38K):
[in this window]
[in a new window]
|
Fig. 7.
Effect of TNF- plus
CHX on intracellular ATP levels. Hp, C33, and mC5 cells were
treated with or without 15 ng/ml TNF- and 40 µM CHX
for 3 h. Intracellular ATP levels were measured using the
luciferin-luciferase reagent as described under "Materials and
Methods." The bar graph shows the relative
luminescence units as a reflection of the intracellular ATP levels in
Hp (white bars), C33 (light-gray bars), and mC5
(dark-gray bars) cells.
|
|
To further evaluate the possible role of energy state or ATP level in
the TNF-
apoptosis in mC5 cells, the cells were incu-bated in MEM,
in a medium lacking glucose/amino acids (phosphate-buffered saline), or
in MEM plus an inhibitor of the mitochondrial respiratory chain
(antimycin A). The cells were then challenged with TNF-
plus CHX for
6 h and assayed for apoptosis by DNA ladder formation or propidium
iodide staining. mC5 cells incubated in MEM plus TNF-
/CHX produced
the expected DNA ladder (Fig.
8A, compare lanes 2 and 3; mC5 cells incubated without TNF-
/CHX). However, a
DNA ladder was not produced when mC5 cells were incubated with
TNF-
/CHX either in PBS (lane 4) or in MEM plus antimycin
A (lane 5). Moreover, if the PBS was removed from the system
and replaced with MEM plus TNF-
/CHX, a DNA ladder was then observed
(lane 6), showing that the PBS incubation did not
irreversibly prevent sensitivity of the cells to TNF-
. Results with
propidium iodide staining are shown in Fig. 8B. Incubation
of mC5 cells with TNF-
/CHX in MEM resulted in a 4-fold increase in
cell staining in the hypodiploid M1 zone, from a control value of 7%
in the absence of TNF-
to a value of 27% in the presence of
TNF-
. The percent apoptotic cells for the TNF-
/CHX incubation in
PBS was only 11%, and that for cells incubated in MEM plus
antimycin A was 10%. Energized conditions appear to be necessary for
the TNF-
/CHX induction of apoptosis.

View larger version (49K):
[in this window]
[in a new window]
|
Fig. 8.
Effect of PBS or antimycin A on apoptosis
induced by TNF- . mC5 cells were incubated
with PBS for 2 h, with MEM containing 15 µM
antimycin A for 8 h, or with just MEM for 6 h, followed by
addition of 10 ng/ml TNF- and 40 µM CHX for a further
6 h of incubation. A, DNA fragmentation. DNA was
extracted and electrophoresed on a 1.5% agarose gel. Lane
1, 100-base pair standard ladder; lane 2, cells
incubated with PBS alone for 8 h; lane 3, cells
incubated with MEM and TNF- /CHX for 6 h; lane 4,
cells incubated with PBS for 2 h and then treated with PBS
containing TNF- /CHX for 6 h; lane 5, cells incubated
with antimycin A for 8 h and then treated with medium containing
TNF- /CHX for 6 h; lane 6, cells incubated with PBS
for 8 h and then treated with MEM containing TNF- /CHX for an
additional 6 h. B, histograms of DNA
analysis by flow cytometry. Panel a, mC5 cells incubated
with PBS; panel b, cells incubated with MEM containing
TNF- /CHX for 6 h; panel c, cells incubated with PBS
for 2 h and then treated with PBS containing TNF- /CHX for
6 h; panel d, cells incubated with antimycin A for
8 h and then treated with MEM containing TNF- /CHX for 6 h.
The percentages of cells in the zone 1 hypodiploid area are depicted on
the graphs.
|
|
 |
DISCUSSION |
Mitochondria are a main source of ROS generation including
H2O2 and an important target for interaction
with H2O2; mitochondria are also a critical
organelle for cells undergoing apoptosis since they can release
cytochrome c or other apoptotic factors to the cytoplasm,
which eventually leads to the activation of caspases (1, 23-25). Many
apoptotic stimulators, similar to TNF-
, are able to induce the
generation of ROS by interaction with the respiratory chain (6, 36),
and ROS are thought to be mediators in the apoptotic pathway (37, 38).
Low levels of H2O2 can cause apoptosis, whereas
higher levels lead to necrosis (7, 8); and H2O2 plays a key role in the cytotoxicity and apoptosis induced by ceramide,
antimycin A, arsenite, and TNF-
(38-40).
H2O2 can induce a mitochondrial permeability
transition and decrease the mitochondrial membrane potential (41-43).
The primary enzymatic defense against H2O2 in
mitochondria is the glutathione peroxidase system, as catalase is not
present in mitochondria from most tissues. Because mitochondria are an
important target for interaction with H2O2 and
since they lack catalase, we developed a HepG2 cell line that expresses
catalase in the mitochondrial compartment and compared the
effectiveness of overexpression of catalase in mitochondria with that
of overexpression of catalase in the cytosol in protecting HepG2 cells
against toxin-induced injury. With respect to
H2O2, menadione, or antimycin A, catalase
overexpressed in the mitochondrial compartment was generally as
effective as catalase overexpressed in the cytosolic compartment in
protecting against the loss of cell viability produced by these agents
(21).
In the present study, similar experiments were carried out with TNF-
as the toxic insult to HepG2 cells. In contrast to the previous results
with H2O2, menadione, or antimycin A, the cells overexpressing catalase showed an increased sensitivity to TNF-
plus
CHX. mC5 cells were the most sensitive to TNF-
-induced apoptosis, and these cells displayed the highest caspase-3 activity in response to
TNF-
addition. The somewhat unique sensitivity to TNF-
when catalase is expressed in the mitochondrial compartment may be related
to the propensity of TNF-
to increase ROS production in
mitochondria. Hence, mitochondrial catalase may be more effective than
cytosolic catalase in removal of H2O2 produced
as a consequence of TNF-
interactions with the mitochondrial
respiratory chain.
These considerations would suggest that H2O2 is
preventing or limiting a full apoptotic response to TNF-
. To
evaluate this, we first showed that azide, an inhibitor of catalase,
protected against the TNF-
-induced apoptosis and activation of
caspase-3 in all three cell lines and prevented the elevated apoptosis
and caspase-3 activity in mC5 cells. Addition of
H2O2 at concentrations and for incubation times
that by themselves had no effect on cellular viability also protected
against the TNF-
-induced apoptosis and activation of caspase-3 in
all three cell lines and prevented the elevated apoptosis and caspase-3
activation in mC5 cells. These actions of azide and of added
H2O2 are supportive of the concept that
H2O2 limits a complete apoptotic response to
TNF-
.
Why would H2O2 limit the ability of TNF-
to
induce apoptosis? The observations that a pan-caspase inhibitor
strongly prevented apoptosis in all three cell lines and that added
H2O2 was a powerful inhibitor of caspase-3
activity suggested that the latter action of
H2O2 was responsible for the negative effect of
H2O2 on apoptosis. TNF-
/CHX activated
caspase-3 by causing cleavage of procaspase-3 into catalytically active
fragments. H2O2 and Z-VAD-fmk inhibit the
cleavage of procaspase-3 induced by TNF-
/CHX. It is also likely that
H2O2 could inhibit caspase activity directly by
oxidizing cysteine residues required for the activity of these enzymes. In a cell-free system, we observed that H2O2
suppresses the activity of activated caspase-3 (data not show).
Recent studies have shown that the execution of apoptosis requires the
maintenance of adequate intracellular ATP levels (44-46). Energy
failure and concomitant ATP depletion affect one or more steps of the
apoptotic program and preclude the activation of execution processes,
which are required for apoptotic morphology changes (46). A decrease in
ATP generation by inhibiting the mitochondrial respiratory chain with
rotenone, antimycin A, or an inhibitor of ATP synthase prevented cells
from undergoing apoptosis or switched cellular toxicity to necrosis
(35). We therefore investigated the basal ATP level as well as the
changes in ATP levels after treatment with TNF-
/CHX in the three
cell lines. In the absence of TNF-
/CHX treatment, ATP levels were
~2-fold higher in C33 cells than in Hp or mC5 cells. Although the
reason for this has not been studied, one possible explanation could involve the known sensitivity of glyceraldehyde-3-phosphate
dehydrogenase, a key glycolytic enzyme, to oxidative stress and
H2O2 (47). Since this enzyme is largely located
in the cytosolic compartment, cytosolic catalase would probably be most
effective in preventing endogenous
H2O2-mediated loss of activity. Most of the ATP
produced in HepG2 cells is via glucose metabolism, which requires
glycolysis as the initial step. Treatment with TNF-
plus CHX
increases intracellular ATP levels in all three cell lines;
however, the levels of ATP were higher in C33 and mC5 cells than in Hp
cells. These elevated ATP levels may be permissive for apoptosis (35,
44-46). We cultured mC5 cells in PBS rather than MEM or added
antimycin A to the MEM system; under these conditions of lower energy
production, TNF-
-induced apoptosis was decreased, indicating that an
energized state or ATP was required for the TNF-
/CHX-induced apoptosis.
Based upon the above, the following model is proposed. TNF-
activates a signal transduction pathway ultimately resulting in
cellular apoptosis. TNF-
increases mitochondrial production of
H2O2; H2O2 may limit a
full apoptotic response to TNF-
by two mechanisms. One mechanism
involves inhibition of caspase-3 activity either via preventing
cleavage of procaspase-3 or by direct inhibition of caspase-3; it is
possible that the H2O2 is also modulating the
activity of upstream caspases responsible for eventual cleavage of
procaspase-3. A second mechanism may reflect the lower ATP levels in Hp
cells compared with C33 and mC5 cells, as the TNF-
-increased
production of ROS may limit the state 3 respiratory rate or may
partially dissipate the transmembrane energy potential. Overexpression
of catalase in the cytosol or especially in mitochondria efficiently
removes the H2O2 produced by TNF-
, allowing
increased activation of caspase-3 and maximal rates of ATP synthesis to
occur. This sequence of events results in an enhanced response to
TNF-
-induced apoptosis. The comparable activation of NF-
B and
AP-1 by TNF-
in the three cell lines suggests that the
overexpression of catalase did not alter TNF-
signal transduction
pathways. Although further studies are necessary to evaluate the above
model, the different sensitivities to toxins such as TNF-
versus menadione or antimycin A emphasize the complexity in
attempting to predict the effectiveness of antioxidant enzymes such as
catalase and their possible therapeutic effectiveness.
 |
ACKNOWLEDGEMENTS |
We thank Dr. J. Andres Melendez (Department
of Biochemistry and Molecular Biology, Albany Medical College) for
providing the various plasmids and for helpful discussion and
Montserrat Marí for help with the electrophoretic mobility
shift assays.
 |
FOOTNOTES |
*
This work was supported by United States Public Health
Service Grants AA03312 and AA06610 from the National Institute on
Alcohol Abuse and Alcoholism.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Biochemistry
and Molecular Biology, Mount Sinai School of Medicine, P. O. Box 1020, One Gustave L. Levy Place, New York, NY 10029. Tel.: 212-241-7285; Fax:
212-996-7214; E-mail: Acederb@smtplink.mssm.edu.
Published, JBC Papers in Press, April 6, 2000, DOI 10.1074/jbc.M000438200
 |
ABBREVIATIONS |
The abbreviations used are:
ROS, reactive oxygen
species;
TNF-
, tumor necrosis factor-
;
CHX, cycloheximide;
MEM, minimal essential medium;
PBS, phosphate-buffered saline;
NF-
B, nuclear factor
B;
Z-VAD-fmk, benzyloxycarbonyl-Val-Ala-Asp
fluoromethyl ketone.
 |
REFERENCES |
| 1.
|
Green, D. R.,
and Reed, J. C.
(1998)
Science
281,
1309-1312
|
| 2.
|
Mignotte, B.,
and Vayssiere, J. L.
(1998)
Eur. J. Biochem.
252,
1-15
|
| 3.
|
Alnemri, E. S.,
Livingston, D. J.,
Nicholson, D. W.,
Salvesen, G.,
Thornberry, N. A.,
Wong, W. W.,
and Yuan, J.
(1996)
Cell
87,
171
|
| 4.
|
Thornberry, N. A.,
and Lazebnik, Y.
(1998)
Science
281,
1312-1316
|
| 5.
|
Samali, A.,
Nordgren, H.,
Zhivotovsky, B.,
Peterson, E.,
and Orrenius, S.
(1999)
Biochem. Biophys. Res. Commun.
255,
6-11
|
| 6.
|
Tan, S.,
Sagara, Y.,
Liu, Y.,
Maher, P.,
and Schubert, D.
(1998)
J. Cell Biol.
141,
1423-1432
|
| 7.
|
Lennon, S. V.,
Martin, S. J.,
and Cotter, T. G.
(1991)
Cell Proliferation
24,
203-214
|
| 8.
|
Hampton, M. B.,
and Orrenius, S.
(1997)
FEBS Lett.
414,
552-556
|
| 9.
|
Lee, Y.,
and Shacter, E.
(1999)
J. Biol. Chem.
274,
19792-19798
|
| 10.
|
Beutler, B.,
and Cerami, A.
(1986)
Nature
320,
584-588
|
| 11.
|
Tracey, K. J.,
Wei, H.,
Manogue, K. R.,
Fong, Y.,
Hesse, D. G.,
Nguyen, H. T.,
Kuo, G. C.,
Beutler, B.,
Cotran, R. S.,
and Cerami, A.
(1988)
J. Exp. Med.
167,
1211-1227
|
| 12.
|
Blazka, M. E.,
Wilmer, J. L.,
Holladay, S. D.,
Wilson, R. E.,
and Luster, M. I.
(1995)
Toxicol. Appl. Pharmacol.
133,
43-52
|
| 13.
|
Czaja, M. J.,
Flanders, K. C.,
Biempica, L.,
Klein, C.,
Zern, M. A.,
and Weiner, F. R.
(1989)
Growth Factors
1,
219-226
|
| 14.
|
McClain, C. J.,
and Cohen, D. A.
(1989)
Hepatology
9,
349-351
|
| 15.
|
Yoshioka, K.,
Kakumu, S.,
Arao, M.,
Tsutsumi, Y.,
and Inoue, M.
(1989)
Hepatology
10,
769-773
|
| 16.
|
Beyaert, R.,
and Fiers, W.
(1994)
FEBS Lett.
340,
9-16
|
| 17.
|
Goossens, V.,
Grooten, J.,
De Vos, K.,
and Fiers, W.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
8115-8119
|
| 18.
|
Zimmerman, R. J.,
Chan, A.,
and Leadon, S. A.
(1989)
Cancer Res.
49,
1644-1648
|
| 19.
|
Wong, G. H.,
Elwell, J. H.,
Oberley, L. W.,
and Goeddel, D. V.
(1989)
Cell
58,
923-931
|
| 20.
|
O'Donnell, V. B.,
Spycher, S.,
and Azzi, A.
(1995)
Biochem. J.
310,
133-141
|
| 21.
|
Bai, J.,
Rodriguez, A. M.,
Melendez, J. A.,
and Cederbaum, A. I.
(1999)
J. Biol. Chem.
274,
26217-26224
|
| 22.
|
Hill, D. B.,
Schmidt, J.,
Shedlofsky, S. I.,
Cohen, D. A.,
and McClain, C. J.
(1995)
Hepatology
21,
1114-1119
|
| 23.
|
Yang, J.,
Liu, X.,
Bhalla, K.,
Kim, C. N.,
Ibrado, A. M.,
Cai, J.,
Peng, T. I.,
Jones, D. P.,
and Wang, X.
(1997)
Science
275,
1129-1132
|
| 24.
|
Zamzami, N.,
Susin, A. S.,
Merchetti, P.,
Hirsch, T.,
Gomez-Monterrey, I.,
Castedo, M.,
and Kroemer, G.
(1996)
J. Exp. Med.
183,
1533-1544
|
| 25.
|
Susin, S. A.,
Lorenzo, H. K.,
Zamzami, N.,
Marzo, I.,
Bernner, C.,
Larochette, N.,
Prevost, M. C.,
Alzari, P. M.,
and Kroemer, G.
(1999)
J. Exp. Med.
189,
381-393
|
| 26.
|
Hu, W. H.,
Johnson, H.,
and Shu, H. B.
(1999)
J. Biol. Chem.
274,
30603-30610
|
| 27.
|
Kohler, H. B.,
Knop, J.,
Martin, M.,
de Bruin, A.,
Huchzermeyer, B.,
Lehmann, H.,
Kietzmann, M.,
Meier, B.,
and Nolte, I.
(1999)
Vet. Immunol. Immunopathol.
71,
125-142
|
| 28.
|
Xu, Y.,
Kiningham, K. K.,
Devalaraja, M. N.,
Yeh, C. C.,
Majima, H.,
Kasarskis, E. J.,
and St. Clair, D. K.
(1999)
DNA Cell Biol.
18,
709-722
|
| 29.
|
Wang, C. Y.,
Guttridge, D. C.,
Mayo, M. W.,
and Baldwin, A. S., Jr.
(1999)
Mol. Cell. Biol.
19,
5923-5929
|
| 30.
|
Kitamura, M.
(1999)
Eur. J. Immunol.
29,
1647-1655
|
| 31.
|
Sumitomo, M.,
Tachibana, M.,
Nakashima, J.,
Murai, M.,
Miyajima, A.,
Kimura, F.,
Hayakawa, M.,
and Nakamura, H.
(1999)
J. Urol.
161,
674-679
|
| 32.
|
Schmidt, K. N.,
Amstad, P.,
Cerutti, P.,
and Baeuerle, P. A.
(1995)
Chem. Biol.
2,
13-22
|
| 33.
|
Eguchi, Y.,
Srinivasan, A.,
Tomaselli, K. J.,
Shimizu, S.,
and Tsujimoto, Y.
(1999)
Cancer Res.
59,
2174-2181
|
| 34.
|
Solary, E.
(1998)
C. R. Seances Soc. Biol. Fil.
192,
1065-1076
|
| 35.
|
Sanchez-Alcazar, J. A.,
Ruiz-Cabello, J.,
Hernandez-Munoz, I.,
Pobre, P. S.,
de la Torre, P.,
Siles-Rivas, E.,
Garcia, I.,
Kaplan, O.,
Munoz-Yague, M. T.,
and Solis-Herruzo, J. A.
(1997)
J. Biol. Chem.
272,
30167-30177
|
| 36.
|
Garcia-Ruiz, C.,
Colell, A.,
Mari, M.,
Morales, A.,
and Fernandez-Checa, J. C.
(1997)
J. Biol. Chem.
272,
11369-11377
|
| 37.
|
Hildeman, D. A.,
Mitchell, T.,
Teague, T. K.,
Henson, P.,
Day, B. J.,
Kappler, J.,
and Marrack, P. C.
(1999)
Immunity
10,
735-744
|
| 38.
|
Sidoti-de Fraisse, C.,
Rincheval, V.,
Risler, Y.,
Mignotte, B.,
and Vayssiere, J. L.
(1998)
Oncogene
17,
1639-1651
|
| 39.
|
Hagar, H.,
Ueda, N.,
and Shah, S. V.
(1996)
Am. J. Physiol.
271,
F209-F215
|
| 40.
|
Chen, Y. C.,
Lin-Shiau, S. Y.,
and Lin, J. K.
(1998)
J. Cell. Physiol.
177,
324-333
|
| 41.
|
Lemasters, J. J.,
Qian, T.,
Elmore, S. P.,
Trost, L. C.,
Nishimura, Y.,
Herman, B.,
Bradham, C. A.,
Brenner, D. A.,
and Nieminen, A. L.
(1998)
Biofactors
8,
283-285
|
| 42.
|
Gores, G. J.,
Miyoshi, H.,
Botla, R.,
Aguilar, H. I.,
and Bronk, S. F.
(1998)
Biochim. Biophys. Acta
1366,
167-175
|
| 43.
|
Hirokawa, M.,
Miura, S.,
Yoshida, H.,
Kurose, I.,
Shigematsu, T.,
Hokari, R.,
Higuchi, H.,
Watanabe, N.,
Yokoyama, Y.,
Kimura, H.,
Kato, S.,
and Ishii, H.
(1998)
Alcohol Clin. Exp. Res.
22 (suppl.),
111S-114S
|
| 44.
|
Leist, M.,
Single, B.,
Castoldi, A. F.,
Kuhnle, S.,
and Nicotera, P.
(1997)
J. Exp. Med.
185,
1481-1486
|
| 45.
|
Eguchi, Y.,
Shimizu, S.,
and Tsujimoto, Y.
(1997)
Cancer Res.
57,
1835-1840
|
| 46.
|
Nicotera, P.,
Leist, M.,
and Ferrando-May, E.
(1998)
Toxicol. Lett.
102-103,
139-142
|
| 47.
|
Chevalier, M.,
Lin, E. C.,
and Levine, R. L.
(1990)
J. Biol. Chem.
265,
42-46
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. M. Connor, N. Hempel, K. K. Nelson, G. Dabiri, A. Gamarra, J. Belarmino, L. Van De Water, B. M. Mian, and J. A. Melendez
Manganese Superoxide Dismutase Enhances the Invasive and Migratory Activity of Tumor Cells
Cancer Res.,
November 1, 2007;
67(21):
10260 - 10267.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. B. Waypa, R. Guzy, P. T. Mungai, M. M. Mack, J. D. Marks, M. W. Roe, and P. |